Table 4.
Distribution of CSF Viral Load by CSF HIV Risk Score Category in 811 Persons With HIV at Study Entry, CHARTER Study Cohort, 2004–2007
Category | Risk Score | No. of Subjects | Log10 CSF Viral Load, mean (SD) |
P Value for Comparison of CSF HIV Risk Score Categories |
|||
---|---|---|---|---|---|---|---|
Versus Category 1 | Versus Category 2 | Versus Category 3 | Versus Category 4 | ||||
1 | 0–10 | 217 | 0.1099 (0.4146) | 0.080 | <0.001 | <0.001 | |
2 | 11–20 | 404 | 0.2716 (0.6800) | 0.080 | <0.001 | <0.001 | |
3 | 21–30 | 145 | 1.4934 (1.1495) | <0.001 | <0.001 | <0.001 | |
4 | 31–39 | 45 | 2.7313 (1.2672) | <0.001 | <0.001 | <0.001 |
Abbreviations: CHARTER, Central Nervous System Human Immunodeficiency Virus Antiretroviral Therapy Effects Research; CSF, cerebrospinal fluid; HIV, human immunodeficiency virus; SD, standard deviation.